Contrast Media: Clinical Trials

85 trials of Contrast Media, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

33 completed, 17 recruiting, 13 active not recruiting, 10 unknown. 33 Not applicable, 14 Phase 2, 7 Phase 4, 6 Phase 1, 5 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable33Completed 16, Recruiting 5, Unknown 4, Active not recruiting 3, Withdrawn 3, Enrolling by invitation 1, Terminated 1
Phase 214Active not recruiting 6, Recruiting 4, Completed 2, Not yet recruiting 1, Terminated 1
Phase 47Completed 3, Active not recruiting 1, Recruiting 1, Terminated 1, Unknown 1
Phase 16Completed 3, Not yet recruiting 1, Recruiting 1, Withdrawn 1
Phase 35Completed 3, Not yet recruiting 1, Recruiting 1
Early Phase 12Active not recruiting 1, Completed 1

Follow Contrast Media: new trials by email Literature Review of Contrast Media trials Research Report on Contrast Media

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety Study of CZ10 in Healthy Volunteers
Contrast Media, Placebo - Healthy Volunteer Study
Phase 1Not yet recruitingNextrast, Inc.242050-01-012024-11-29
PET/MRI of Primary Sclerosing Cholangitis
Radiotracer Injection, Contrast Media, Magnetic Resonance, Imaging - PSC
Not yet recruitingMassachusetts General Hospital102026-12-102026-10-14
PH Weighted Chemical Exchange Saturation Transfer MRI-Based Surgical Resection to Improve Survival in Patients With Glioblastoma
Chemical Exchange Saturation Transfer Magnetic Resonance Imaging, Contrast-enhanced Magnetic Resonance Imaging, Magnetic Resonance Imaging - Glioblastoma
Phase 3Not yet recruitingJonsson Comprehensive Cancer Center602026-12-012026-07-07
Prevalence of Cardiac Thrombi in Cardiac Amyloidosis
Cardiac CT scan with contrast - Cardiac Amyloidosis
Not applicableRecruitingCentre Hospitalier Universitaire Dijon2002026-09-072026-09-17
Study of the Hypothalamic Microglial Response as a Function of a Meal's Lipid Content in Humans. A Single-center Prospective Cohort Study in Healthy Male Subjects
Blood sample, Brain MRI without contrast, performed on an empty stomach and after a meal, Questionnaires - Pathophysiology
RecruitingCentre Hospitalier Universitaire Dijon202026-09-052026-09-29
Screening for Brain Metastases
gadopiclenol (contrast agent), standard contrast agent - Lung Cancer Stage IV, Melanoma Stage IV
Phase 2Not yet recruitingUniversity of Zurich1802026-09-012026-03-25
A Screening Program to Improve the Early Detection of Sporadic Pancreatic Cancer in Individuals With a High-Risk of Developing Pancreatic Cancer
Biospecimen Collection, Computed Tomography with Contrast, Electronic Health Record Review - Pancreatic Ductal Adenocarcinoma
Not applicableRecruitingMayo Clinic1002026-03-242026-10-14
ELUDYN: Assessment of Intra-individual Variability of Vascular Dynamics of Gadopiclenol Injection Parameters in Contrast-enhanced MRI
contrast agent, Gadolinium - Contrast Agent, Medical Imaging Data
Phase 4Active not recruitingHôpital Fribourgeois142026-01-072026-04-29
A Study of SCAD Using Stress Contrast Echocardiography
Stress Echocardiography with Contrast - Spontaneous Coronary Artery Dissection
RecruitingMayo Clinic502025-11-252026-01-07
Contribution of Contrast Enhanced Ultrasound for Diagnosis of Adnexal Torsion
Addition of ultrasound with contrast injection (SonoVue®), Standard Care (in control arm) - Adnexal Torsion
Phase 3RecruitingCentral Hospital, Nancy, France2562025-05-142026-04-08
Study on Sex-specific, Individualized Dose Calculation of Contrast Agent in CT Examinations
contrast media (Imeron 350, active ingredient Iomeprol) volume according to sex-specific blood volume - CT Scans, Contrast Media
Not applicableRecruitingUniversity Hospital Augsburg4002025-04-012025-12-09
Autopsy and Photon Counting Computed Tomography to Evaluate Thromboses Related to Central Venous Catheters
Diseased patients with an indwelling central venous catheter who is referred to autopsy, Living patients with an indwelling central venous catheter referred to a CT scan without iv contrast - Central Venous Catheter Thrombosis
RecruitingThomas Kander752025-01-162026-04-28
Dexamethasone and Azeliragon for Management of Post-Resection Cerebral Edema in Patients with Glioblastoma
Azeliragon, Biospecimen Collection, Computed Tomography - Glioblastoma, Malignant Glioma
Phase 1WithdrawnCity of Hope Medical Center2024-11-152024-09-19
Brain Volume and Cardiac Function in Heart Failure
Magnetic Resonance Imaging with or without Contrast - Heart Failure
Not applicableCompletedJohns Hopkins University122024-11-102026-07-17
To Evaluate Dose and Safety of NanoEcho Particle-1 Using NanoEcho Imaging Device Examinations of Rectal Lymph Nodes in Healthy Volunteers and Rectal Cancer Patients.
Iron oxide nanoparticles, Rectal Magnetomotoric ultrasound (MMUS) - Healthy Volunteers, Rectal Cancer Patients
Phase 2RecruitingNanoEcho AB122024-10-292024-11-18
Development of MRF for Characterization of Brain Tumors After Radiotherapy
MRF in conjunction with IVIM MRI without contrast - Brain Tumor, Brain Necrosis
Not applicableRecruitingCase Comprehensive Cancer Center902024-10-142026-10-20
Multivariate Analysis and Risk Factors Were Used to Predict the Short-term Postoperative Pain of Degenerative Lumbar Spine
Magnetic Resonance Imaging with Contrast - Lumbar Disc Herniation, Lumbar Degenerative Disease
CompletedHao Liu9362024-09-202024-10-08
Effects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate Cancer
Biospecimen Collection, Contrast Agent, Leuprolide - Prostate Adenocarcinoma, Stage IIB Prostate Cancer AJCC v8
Phase 2RecruitingOhio State University Comprehensive Cancer Center702024-08-122026-03-09
Value of PET/MR Enterography in the Assessment of Crohn's Disease Using a Collagen-binding Radiotracer.
Radiotracer Injection, Contrast Media, Magnetic Resonance, Blood Draw - Crohn Disease
RecruitingMassachusetts General Hospital252023-12-192026-03-12
Developing a New Metabolic Imaging Approach (aMRI) for Evaluating Neurological Disease in Patients With Gliomas
Fludeoxyglucose F-18, Gadoterate Meglumine, Contrast-enhanced Magnetic Resonance Imaging - Glioma
CompletedOHSU Knight Cancer Institute42023-12-112026-06-05

Showing 20 of 85. Sign in to see all of them.

Conditions studied

Coronary Artery Disease (7)  ·  Lung Neoplasms (5)  ·  Breast Neoplasms (3)  ·  Carcinoma, Non-Small-Cell Lung (3)  ·  Glioblastoma (3)  ·  Glioma (3)  ·  Myocardial Infarction (3)  ·  Acute Kidney Injury (2)  ·  Atherosclerosis (2)  ·  Cardiovascular Diseases (2)  ·  Carotid Artery Diseases (2)  ·  Fibrosis (2)  ·  Head and Neck Neoplasms (2)  ·  Thrombosis (2)  ·  Acute Coronary Syndrome (1)

Sponsors

National Cancer Institute (NCI) (7)  ·  Cedars-Sinai Medical Center (5)  ·  M.D. Anderson Cancer Center (3)  ·  St. Jude Children's Research Hospital (3)  ·  Centre Hospitalier Universitaire Dijon (2)  ·  City of Hope Medical Center (2)  ·  Massachusetts General Hospital (2)  ·  Mayo Clinic (2)  ·  NYU Langone Health (2)  ·  Ohio State University Comprehensive Cancer Center (2)  ·  Stanford University (2)  ·  University Health Network, Toronto (2)  ·  University of Michigan (2)  ·  Assiut University (1)  ·  Astellas Pharma Inc (1)

Countries

United States (48)  ·  France (7)  ·  Canada (5)  ·  China (4)  ·  Germany (3)  ·  Italy (3)  ·  South Korea (3)  ·  Sweden (3)  ·  Switzerland (3)  ·  United Kingdom (3)  ·  Egypt (2)  ·  Netherlands (2)  ·  Argentina (1)  ·  Austria (1)  ·  Belgium (1)

Top investigators

Debiao Li, PhD (2)  ·  Onofrio Catalano, MD, Ph.D (2)  ·  Ajit H. Goenka, MD (1)  ·  Amanda Cashen, M.D. (1)  ·  Amer Johri, MD (1)  ·  Andrew B Lassman (1)  ·  Anishka A D'Souza (1)  ·  Bernd Tombach, MD (1)  ·  Bruce M. Barack, M.D. (1)  ·  Chelsea Kidwell, MD (1)  ·  Dan Raz (1)  ·  Daniel Ennis, PhD (1)

Results publications

PMID 24314823, PMID 25977304, PMID 26068287, PMID 26777226, PMID 27013162, PMID 27101902, PMID 27282899, PMID 27385151, PMID 27751505, PMID 28086778, PMID 28728652, PMID 28874779, PMID 29042397, PMID 29050557, PMID 29361484, PMID 29432486, PMID 30115688, PMID 30679214, PMID 31101367, PMID 31917762, PMID 32691060, PMID 33607632, PMID 34503740, PMID 34503741, PMID 35483358, PMID 37084748, PMID 37220640, PMID 37264699, PMID 39234878, PMID 39748640, PMID 40178463, PMID 40779733, PMID 41699282

NIH funding

U10CA180868 (3), P30CA033572 (2), 2009 (1), 2025 (1), K23HL155506 (1), P30CA014089 (1), P30CA072720 (1), R01CA262388 (1), R01EB002623 (1), R01HL124649 (1), R01HL131975 (1), U10CA180820 (1), U10CA180821 (1), U19CA264512 (1), UM1CA186717 (1)